NRX Pharmaceuticals, Inc. Warrant — Institutional Ownership
Which tracked institutions hold NRXPW, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
12
Funds holding
$7456562
Total value held
Buying
9 added/new · 2 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Ameriprise Financial Inc | $3798498 | 928728 | +928728 | NEW BUY |
| 2 | Ubs Group Ag | $1730540 | 423115 | +423115 | NEW BUY |
| 3 | Blackrock, Inc. | $901681 | 220460 | +121465 | +122.70% |
| 4 | State Street Corp | $474784 | 116084 | +29100 | +33.45% |
| 5 | Northern Trust Corp | $257470 | 62951 | +19482 | +44.82% |
| 6 | Morgan Stanley | $167285 | 40901 | +30873 | +307.87% |
| 7 | Truist Financial Corp | $81800 | 20000 | +20000 | NEW BUY |
| 8 | Citigroup Inc | $24507 | 5992 | +5992 | NEW BUY |
| 9 | Wells Fargo & Company/Mn | $8180 | 2000 | -350 | -14.89% |
| 10 | Royal Bank Of Canada | $8000 | 2000 | -509 | -20.29% |
| 11 | Barclays Plc | $3681 | 900 | +900 | NEW BUY |
| 12 | Jpmorgan Chase & Co | $136 | 34 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.